see
editori
commentari
musher
page
jain
pavia
page
background
frequent
lack
microbiolog
diagnosi
communityacquir
pneumonia
cap
impair
pathogendirect
antimicrobi
therapi
studi
assess
use
comprehens
multibacteri
multivir
molecular
test
includ
quantif
adult
hospit
cap
method
clinic
laboratori
data
collect
adult
radiologicallyconfirm
cap
admit
uk
tertiari
care
hospit
sputum
endotrach
aspir
specimen
cultur
per
routin
practic
also
test
fast
multiplex
realtim
polymerasechain
reaction
pcr
assay
respiratori
bacteria
virus
bacteri
load
also
calcul
bacteri
pathogen
appropri
pathogendirect
therapi
retrospect
assess
use
nation
guidelin
adapt
local
antimicrobi
suscept
pattern
result
comprehens
molecular
test
singl
lower
respiratori
tract
lrt
specimen
achiev
pathogen
detect
cap
patient
compar
culturebas
method
haemophilu
influenza
streptococcu
pneumonia
main
agent
detect
along
wide
varieti
typic
atyp
pathogen
virus
present
case
codetect
bacteria
patient
receiv
antimicrobi
hour
admiss
bacteri
pathogen
detect
pcr
cultureposit
p
molecular
test
potenti
enabl
deescal
number
andor
spectrum
antimicrobi
patient
conclus
comprehens
molecular
test
significantli
improv
pathogen
detect
cap
particularli
antimicrobialexpos
patient
requir
singl
lrt
specimen
also
potenti
enabl
earli
deescal
broadspectrum
empir
antimicrobi
pathogendirect
therapi
communityacquir
pneumonia
cap
common
infecti
diseas
estim
incid
case
per
adult
develop
world
mortal
rate
due
rang
pathogen
respons
cap
moder
sever
infect
broadspectrum
antimicrobi
cover
initi
deescal
narrowspectrum
pathogendirect
agent
microbiolog
diagnosi
made
unfortun
deescal
uncommon
practic
current
diagnost
method
may
identifi
pathogen
patient
cap
recent
studi
highlight
need
time
sensit
microbiolog
diagnost
method
cap
particularli
bacteria
common
scenario
antibiot
administr
prior
sampl
develop
multiplex
realtim
polymerasechain
reaction
pcr
assay
current
enabl
respiratori
specimen
rapidli
screen
wide
rang
viral
atyp
bacteri
pathogen
small
number
reaction
howev
similar
approach
yet
adopt
typic
bacteri
pathogen
difficult
interpret
pcr
result
typic
respiratori
bacteria
nonsteril
sampl
sputum
due
potenti
contamin
organ
oropharyng
flora
howev
accur
molecular
quantif
bacteri
load
may
aid
distinguish
infect
contamin
way
analog
use
quantit
cultur
quantit
molecular
assay
typic
respiratori
bacteria
use
previous
patient
pneumonia
assay
lack
number
key
target
use
target
shown
lack
specif
may
semiquantit
howev
group
recent
develop
suitabl
assay
capabl
quantifi
bacteri
load
typic
bacteri
pathogen
lower
respiratori
tract
lrt
specimen
assay
extens
valid
clinic
isol
refer
strain
clinic
specimen
sputa
bronchoalveolar
lavag
fluid
bacteri
target
could
reliabl
quantifi
even
present
mixtur
differ
concentr
aim
studi
assess
util
comprehens
molecular
diagnost
approach
encompass
respiratori
bacteri
viral
pathogen
includ
bacteri
quantif
patient
cap
patient
present
tertiari
care
hospit
edinburgh
unit
kingdom
period
septemb
februari
consecut
case
clinic
radiolog
evid
cap
identifi
daili
retrospect
electron
review
respiratori
sampl
receiv
microbiolog
laboratori
inclus
criteria
studi
includ
follow
adult
age
year
lrt
specimen
obtain
within
hour
admiss
hospit
new
radiograph
infiltr
determin
radiologist
consult
respiratori
physician
follow
sign
symptom
new
worsen
cough
new
worsen
expector
sputum
hemoptysi
new
worsen
dyspnea
pleurit
chest
pain
fever
headach
abnorm
chest
auscult
percuss
exclus
criteria
includ
follow
bronchiectasi
cystic
fibrosi
healthcareassoci
pneumonia
hospit
acut
care
hospit
day
within
day
infect
resid
nurs
home
longterm
care
facil
radiolog
report
review
patient
patient
radiolog
chang
consist
pneumonia
includ
uncertainti
imag
review
experienc
respiratori
physician
h
clinic
data
includ
comorbid
outcom
antibiot
prescript
collect
retrospect
patient
hospit
record
use
standard
pro
forma
part
clinic
audit
pneumonia
manag
approv
qualiti
improv
team
royal
infirmari
edinburgh
drug
administr
prior
hospit
includ
antibiot
prescript
obtain
electron
primari
care
prescript
record
admiss
later
verifi
pharmacist
lrt
specimen
cultur
accord
nation
standard
protocol
detect
common
respiratori
bacteria
isol
identifi
use
standard
biochem
method
andor
matrixassist
laser
desorptionion
timeofflight
bruker
coventri
unit
kingdom
specimen
name
bacteri
speci
identifi
cultur
consid
cultur
posit
follow
routin
cultur
lrt
specimen
centrifug
mucopurul
materi
store
month
part
studi
protocol
specimen
associ
clinic
data
collect
anonym
molecular
test
accord
local
ethic
approv
south
east
scotland
scottish
academ
health
scienc
collabor
human
annot
bioresourc
refer
thaw
specimen
homogen
vortex
steril
glass
bead
aliquot
treat
lysozym
follow
proteinas
k
hour
total
nucleic
acid
extract
use
autom
nuclisen
easymag
basingstok
unit
kingdom
instrument
offboard
lysi
protocol
includ
addit
phocin
herp
viru
intern
extract
control
extract
store
day
longer
fast
multiplex
realtim
pcr
perform
use
combin
multiplex
assay
develop
adapt
inhous
follow
previous
describ
bacteri
load
pneumonia
h
influenza
catarrhali
aureu
e
coli
k
pneumonia
p
aeruginosa
baumannii
express
coloni
form
unit
cfu
per
millilit
purul
materi
calcul
standard
curv
gener
target
gene
plasmid
dilut
seri
pcr
run
qualiti
control
reaction
quantit
realtim
pcr
gapdh
human
gene
qualit
realtim
pcr
gb
phocin
herp
viru
intern
control
ic
carri
specimen
quantit
gapdh
pcr
use
indic
cell
content
specimen
gapdh
gene
present
human
dna
neg
templat
control
includ
everi
extract
pcr
run
check
puriti
reagent
run
accept
neg
control
neg
standard
curv
linear
run
fail
qualiti
control
repeat
qualit
result
accept
intern
control
posit
least
target
posit
quantit
result
accept
intern
control
quantif
cycl
cq
valu
fell
within
rang
log
cq
differ
neg
extract
control
outsid
rang
quantit
result
accept
due
potenti
partial
pcr
inhibit
lead
inaccuraci
measur
prescrib
empir
therapi
patient
compar
antimicrobi
would
appropri
pathogendirect
therapi
base
molecular
identif
result
appropri
pathogendirect
therapi
determin
use
uk
nation
guidelin
adapt
local
antimicrobi
suscept
pattern
supplementari
tabl
categor
variabl
compar
use
fisher
exact
test
test
continu
data
assess
use
shapirowilk
w
test
nonnorm
analyz
use
mannwhitney
u
test
test
mcnemar
test
use
compar
pair
proport
bonferroni
method
use
correct
multipl
comparison
signific
test
control
potenti
confound
factor
affect
associ
outcom
infect
use
logist
regress
analysi
analysi
outcom
infect
combin
outcom
measur
mortal
andor
intens
care
unit
icu
admiss
use
infrequ
occurr
either
event
cohort
data
analyz
use
statsdirect
softwar
version
altrincham
unit
kingdom
total
hospit
adult
patient
cap
includ
studi
cohort
male
median
age
year
tabl
critic
care
admiss
icu
highdepend
unit
requir
patient
admit
specif
icu
total
mortal
total
lrt
specimen
receiv
patient
sputa
endotrach
aspir
culturebas
microbiolog
test
identifi
bacteri
pathogen
patient
specimen
posit
pcr
human
gene
target
gapdh
averag
load
gene
copi
per
reaction
specimen
met
qualiti
control
criteria
qualit
molecular
test
bacteria
detect
molecular
test
specimen
patient
tabl
cutoff
cfuml
appli
assay
bacteri
load
quantifi
bacteria
detect
specimen
patient
includ
respiratori
viru
result
overal
pathogen
detect
molecular
test
rose
n
tabl
h
influenza
pneumonia
frequent
identifi
bacteria
patient
cap
detect
patient
respect
detect
bacteri
speci
occur
patient
h
influenza
pneumonia
present
codetect
virus
detect
patient
tabl
rhinoviru
commonli
detect
n
follow
influenza
ab
n
howev
virus
alon
found
patient
virus
codetect
bacteria
tabl
common
combin
rhinoviru
h
influenza
andor
pneumonia
case
pcr
detect
significantli
h
influenza
pneumonia
catarrhali
aureu
e
coli
k
pneumonia
standard
culturebas
method
supplementari
tabl
cultureposit
specimen
also
pcr
posit
speci
bacteria
discrep
specimen
h
influenza
cultur
posit
cultur
neg
pcr
significantli
pcr
abl
detect
bacteria
cultureneg
specimen
specimen
patient
grew
bacteria
includ
pcr
assay
supplementari
tabl
bacteri
load
quantif
specimen
exclud
analysi
due
detect
partial
inhibit
ic
assay
higher
bacteri
load
detect
pcr
cultureposit
specimen
comparison
cultureneg
specimen
mean
combin
bacteri
load
cfuml
cultureposit
vs
cfuml
cultureneg
specimen
p
signific
differ
cultureposit
cultureneg
specimen
also
observ
h
influenza
p
pneumonia
p
consid
individu
neither
cultureposit
pcrposit
associ
outcom
infect
p
odd
ratio
confid
interv
ci
p
ci
respect
polymicrobi
detect
also
associ
outcom
infect
p
ci
bacteri
load
pneumonia
associ
outcom
infect
univari
analysi
higher
load
present
patient
mortal
andor
icu
admiss
cfuml
vs
cfuml
p
howev
score
confus
new
onset
blood
urea
nitrogen
mmoll
respiratori
rate
breath
per
minut
blood
pressur
mmhg
systol
mmhg
diastol
age
year
also
associ
outcom
univari
analysi
p
logist
regress
use
correct
score
patient
pneumonia
infect
bacteri
load
longer
significantli
associ
outcom
p
supplementari
tabl
patient
inform
avail
antimicrobi
administr
prior
sampl
receiv
antimicrobi
either
hospit
commun
hour
lrt
specimen
obtain
prior
antimicrobi
administr
significantli
associ
patient
cultureneg
lrt
specimen
p
ci
patient
receiv
prior
antimicrobi
n
bacteri
pathogen
detect
pcr
n
cultur
posit
p
mean
combin
load
detect
bacteria
per
patient
significantli
higher
patient
receiv
antimicrobi
prior
sampl
cfuml
compar
receiv
antimicrobi
cfuml
p
record
antimicrobi
treatment
hospit
avail
n
patient
molecular
test
potenti
lead
deescal
number
andor
spectrum
initi
empir
antibiot
agent
patient
escal
number
andor
spectrum
antibiot
agent
patient
chang
patient
tabl
major
potenti
deescal
event
relat
switch
amoxicillinclavulan
narrowerspectrum
agent
amoxicillin
doxycyclin
case
pneumonia
h
influenza
detect
pcr
remov
clarithromycin
case
atyp
bacteria
detect
pcr
studi
demonstr
use
comprehens
multibacteri
multivir
molecular
test
approach
approxim
doubl
pathogen
detect
patient
cap
well
provid
valuabl
inform
individu
bacteri
load
test
carri
within
work
day
enabl
report
result
clinic
relev
timefram
requir
singl
lrt
specimen
neg
impact
antibiot
administr
prior
sampl
limit
quantit
molecular
bacteri
test
carri
welldefin
cap
set
studi
focus
test
sputum
molecular
method
high
level
pathogen
detect
typic
bacteria
may
directli
compar
result
recent
studi
hospit
adult
cap
combin
sever
methodolog
serolog
cultur
antigen
detect
pcr
multipl
sampl
type
etiolog
determin
case
atyp
bacteria
uncommon
cohort
patient
epidem
period
pneumonia
virus
detect
approxim
one
third
patient
agreement
rang
report
previou
studi
influenza
also
detect
compar
level
although
abl
test
control
viral
detect
pcr
upper
respiratori
tract
found
rare
asymptomat
adult
compar
cap
recent
studi
one
limit
studi
restrict
cap
patient
could
produc
sputum
specimen
also
includ
blood
cultur
urinari
antigen
test
sputum
pragmat
although
imperfect
choic
specimen
type
microbiolog
investig
cap
microscopi
sputum
qualiti
routin
carri
local
howev
mucopurul
materi
test
cellular
content
quantifi
human
gapdh
gene
pcr
rule
salivari
specimen
howev
sputum
expector
lower
airway
alway
risk
oropharyng
flora
contamin
despit
limit
nation
cap
guidelin
recommend
sputum
investig
patient
admit
hospit
moder
sever
cap
aid
microbiolog
diagnosi
order
guid
therapi
well
surveil
altern
lower
respiratori
specimen
type
bronchoalveolar
lavag
fluid
may
expect
less
risk
contamin
requir
semiinvas
procedur
certainli
routin
nonintub
patient
key
strength
studi
avail
quantit
bacteri
load
output
addit
qualit
detect
result
quantif
bacteri
dna
load
may
import
distinguish
infect
oropharyng
contamin
sputum
molecular
work
done
date
focus
pneumonia
cutoff
gene
copiesml
typic
describ
signific
threshold
cutoff
cfuml
also
gener
agre
upon
sputum
cultur
determin
year
experi
base
data
appli
signific
threshold
cfu
ml
bacteri
load
significantli
decreas
overal
pathogen
detect
howev
remain
unclear
whether
singl
molecular
cutoff
relev
bacteri
speci
whether
cutoff
sputum
cultur
relev
sputum
pcr
quantit
molecular
tool
mani
bacteri
speci
new
clear
need
explor
role
determin
threshold
signific
nonsignific
detect
key
target
futur
work
found
higher
mean
bacteri
load
pcr
cultureposit
specimen
comparison
cultureneg
specimen
howev
cultureneg
group
frequent
antibiot
expos
antibiot
exposur
also
associ
lower
bacteri
load
pcr
abl
detect
dead
well
viabl
bacteria
clear
long
bacteri
load
might
detect
initi
appropri
antibiot
patient
cap
monitor
bacteri
load
pcr
would
use
patient
quantit
molecular
tool
avail
relev
bacteria
issu
also
investig
recent
review
note
intervent
reduc
excess
increas
effect
antibiot
prescrib
hospit
patient
posit
impact
antimicrobi
resist
hospitalacquir
infect
clinic
outcom
howev
studi
pneumonia
set
small
either
focus
atyp
bacteria
virus
nonquantit
molecular
detect
bacteria
demonstr
antibiot
modif
respect
result
comprehens
molecular
test
studi
avail
treat
physician
due
anonym
studi
protocol
howev
estim
deescal
andor
reduct
number
agent
might
occur
three
quarter
cap
patient
base
significantli
improv
bacteri
detect
capabl
high
rate
broadspectrum
empir
antibiot
usag
cohort
knowledg
local
antimicrobi
resist
pattern
clearli
larg
number
addit
factor
influenc
antimicrobi
select
eg
sever
ill
concurr
infect
site
lower
respiratori
tract
drug
allergi
antimicrobi
suscept
test
inflammatori
marker
suggest
sputum
pcr
test
alon
suffici
howev
lack
posit
microbiolog
identif
signific
issu
highli
like
enhanc
detect
pathogen
report
bacteri
load
would
major
impact
clinic
decisionmak
process
therefor
studi
illustr
feasibl
provid
physician
significantli
inform
base
treatment
decis
current
avail
suggest
comprehens
pcr
test
includ
bacteri
load
quantit
one
input
futur
prospect
studi
area
supplementari
materi
avail
http
cidoxfordjournalsorg
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
author
